Lyra Therapeutics Competitors and Similar CompaniesClear all
Intersect ENT's competitors and similar companies include Acorda Therapeutics and Codiak Biosciences.
 Intersect ENT Intersect ENT (also known as Medtronic Ear, Nose & Throat) is an ear, nose, and throat medical technology company. |  Acorda Therapeutics Acorda Therapeutics is a biotechnology company focused on developing therapies that restore function and improve the lives of people with neurological disorders. |  Codiak Biosciences Codiak Biosciences is a biopharmaceutical company focused on the development of exosome-based therapeutics. | |
Founding Date | Founding Date 2003 | Founding Date 1995 | Founding Date 2015 |
Type | Type Subsidiary | Type Public | Type Public |
Tags | |||
Locations | Locations Menlo Park, US HQ | Locations Ardsley, US HQ Chelsea, US South San Francisco, US Waltham, US | Locations Cambridge, US HQ |
Employees | Employees 4337% increase | Employees 4742% decrease | Employees 992% decrease |
Valuation ($) | Valuation ($) N/A | Valuation ($) 821 k | Valuation ($) 2.8 m |
Financial | |||
Revenue (est.) | Revenue (est.) $106.7m (FY, 2021) | Revenue (est.) $117.6m (FY, 2023) | Revenue (est.) $22.9m (FY, 2021) |
Cost of goods | Cost of goods $30m (FY, 2021) | Cost of goods $15.3m (FY, 2023) | Cost of goods N/A |
Net income | Net income ($159.6m) (FY, 2021) | Net income ($252.9m) (FY, 2023) | Net income ($37.2m) (FY, 2021) |
Operating ⚠ | |||
Products | Products 2 (FY, 2016) | Products N/A | Products 11 (Q2, 2020) |
Funding | |||
Total funding raised | Total funding raised $ 102.9m | Total funding raised N/A | Total funding raised $ 168.5m |
For sources of this data, please see the company profile
View Company Profiles
Acorda Therapeutics
HQ
Ardsley, US
Employees
474↓ 2% decrease
Acorda Therapeutics is a biotechnology company focused on developing therapies that restore function and improve the lives of people with neurological disorders.
View companyCodiak Biosciences
HQ
Cambridge, US
Employees
99↓ 2% decrease
Codiak Biosciences is a biopharmaceutical company focused on the development of exosome-based therapeutics.
View company